Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Payables (2016 - 2025)

Milestone Scientific (MLSS) has disclosed Payables for 16 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Payables rose 104.77% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 104.77% year-over-year, with the annual reading at $1.4 million for FY2025, 104.77% up from the prior year.
  • Payables hit $1.4 million in Q4 2025 for Milestone Scientific, up from $1.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.4 million in Q4 2025 to a low of $104000.0 in Q3 2022.
  • Historically, Payables has averaged $695397.7 across 5 years, with a median of $752383.5 in 2021.
  • Biggest five-year swings in Payables: tumbled 87.63% in 2022 and later surged 586.59% in 2023.
  • Year by year, Payables stood at $780428.0 in 2021, then grew by 4.94% to $819000.0 in 2022, then tumbled by 50.92% to $402000.0 in 2023, then surged by 65.17% to $664000.0 in 2024, then soared by 104.77% to $1.4 million in 2025.
  • Business Quant data shows Payables for MLSS at $1.4 million in Q4 2025, $1.0 million in Q3 2025, and $539000.0 in Q2 2025.